These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35452075)

  • 1. High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA.
    Oh SA; Senger K; Madireddi S; Akhmetzyanova I; Ishizuka IE; Tarighat S; Lo JH; Shaw D; Haley B; Rutz S
    J Exp Med; 2022 May; 219(5):. PubMed ID: 35452075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid-Based Donor Templates for Nonviral CRISPR/Cas9-Mediated Gene Knock-In in Human T Cells.
    Senger K; Akhmetzyanova I; Haley B; Rutz S; Oh SA
    Curr Protoc; 2022 Sep; 2(9):e538. PubMed ID: 36130036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cas9-Cleavage Sequences in Size-Reduced Plasmids Enhance Nonviral Genome Targeting of CARs in Primary Human T Cells.
    Jing R; Jiao P; Chen J; Meng X; Wu X; Duan Y; Shang K; Qian L; Huang Y; Liu J; Huang T; Jin J; Chen W; Zeng X; Yin W; Gao X; Zhou C; Sadelain M; Sun J
    Small Methods; 2021 Jul; 5(7):e2100071. PubMed ID: 34927998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome Editing in CAR-T Cells Using CRISPR/Cas9 Technology.
    Andreu-Saumell I; Rodriguez-Garcia A; Guedan S
    Methods Mol Biol; 2024; 2748():151-165. PubMed ID: 38070114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an in vivo cleavable donor plasmid for targeted transgene integration by CRISPR-Cas9 and CRISPR-Cas12a.
    Ishibashi R; Maki R; Kitano S; Miyachi H; Toyoshima F
    Sci Rep; 2022 Oct; 12(1):17775. PubMed ID: 36272994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells.
    Glaser V; Flugel C; Kath J; Du W; Drosdek V; Franke C; Stein M; Pruß A; Schmueck-Henneresse M; Volk HD; Reinke P; Wagner DL
    Genome Biol; 2023 Apr; 24(1):89. PubMed ID: 37095570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.
    Wang HX; Song Z; Lao YH; Xu X; Gong J; Cheng D; Chakraborty S; Park JS; Li M; Huang D; Yin L; Cheng J; Leong KW
    Proc Natl Acad Sci U S A; 2018 May; 115(19):4903-4908. PubMed ID: 29686087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Additions to the CRISPR Toolbox: CRISPR-
    Shola DTN; Yang C; Kewaldar VS; Kar P; Bustos V
    CRISPR J; 2020 Apr; 3(2):109-122. PubMed ID: 32315232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapy.
    Wellhausen N; Agarwal S; Rommel PC; Gill SI; June CH
    Curr Opin Immunol; 2022 Feb; 74():76-84. PubMed ID: 34798542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells.
    Hu B; Zou Y; Zhang L; Tang J; Niedermann G; Firat E; Huang X; Zhu X
    Hum Gene Ther; 2019 Apr; 30(4):446-458. PubMed ID: 29706119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers.
    Schuh RS; de Carvalho TG; Giugliani R; Matte U; Baldo G; Teixeira HF
    Eur J Pharm Biopharm; 2018 Jan; 122():158-166. PubMed ID: 29122734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene targeting in adult organs using in vivo cleavable donor plasmids for CRISPR-Cas9 and CRISPR-Cas12a.
    Ishibashi R; Maki R; Toyoshima F
    Sci Rep; 2024 Mar; 14(1):7615. PubMed ID: 38556532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced Recycling of an AMA1-Based Genome-Editing Plasmid Allows for Efficient Multiple Gene Deletion/Integration in the Industrial Filamentous Fungus
    Katayama T; Nakamura H; Zhang Y; Pascal A; Fujii W; Maruyama JI
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient simultaneous double DNA knock-in in murine embryonic stem cells by CRISPR/Cas9 ribonucleoprotein-mediated circular plasmid targeting for generating gene-manipulated mice.
    Ozawa M; Taguchi J; Katsuma K; Ishikawa-Yamauchi Y; Kikuchi M; Sakamoto R; Yamada Y; Ikawa M
    Sci Rep; 2022 Dec; 12(1):21558. PubMed ID: 36513736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of exogenous RAD51 enhances the CRISPR/Cas9-mediated genome editing efficiency.
    Park SJ; Yoon S; Choi EH; Hyeon H; Lee K; Kim KP
    BMB Rep; 2023 Feb; 56(2):102-107. PubMed ID: 36513383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy.
    Li C; Mei H; Hu Y
    Brief Funct Genomics; 2020 May; 19(3):175-182. PubMed ID: 31950135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple, fast and efficient iTOP-mediated delivery of CRISPR/Cas9 RNP in difficult-to-transduce human cells including primary T cells.
    Kholosy WM; Visscher M; Ogink K; Buttstedt H; Griffin K; Beier A; Gerlach JP; Molenaar JJ; Geijsen N; de Boer M; Chatsisvili A
    J Biotechnol; 2021 Sep; 338():71-80. PubMed ID: 34271056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome Engineering for Stem Cell Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.